Edwards Skids On Weak Expectations For Its Bread-And-Butter Moneymaker
Edwards Lifesciences stock fell Friday after the company said its TAVR segment will face numerous challenges in the fourth quarter. Continue reading View comments
There is no Profile data available for EWL.BE.
66.94 | |
66.94 | |
- | |
66.94 | |
66.94 | |
54.95-88.06 | |
67 356 M | |
0 | |
0 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Edwards Lifesciences stock fell Friday after the company said its TAVR segment will face numerous challenges in the fourth quarter. Continue reading View comments
In its upcoming report, Edwards Lifesciences (EW) is predicted by Wall Street analysts to post quarterly earnings of $0.67 per share, reflecting an increase of 13.6% compared to the same period last y...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: